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Abstract
Background: Farnesol is a sesquiterpene alcohol produced by many organisms, and also found in several
essential oils. Its role as a quorum sensing molecule and as a virulence factor of Candida albicans has been
well described. Studies revealed that farnesol affect the growth of a number of bacteria and fungi, pointing
to a potential role as an antimicrobial agent.
Methods:  Growth assays of Paracoccidioides brasiliensis cells incubated in the presence of different
concentrations of farnesol were performed by measuring the optical density of the cultures. The viability
of fungal cells was determined by MTT assay and by counting the colony forming units, after each farnesol
treatment. The effects of farnesol on P. brasiliensis dimorphism were also evaluated by optical microscopy.
The ultrastructural morphology of farnesol-treated P. brasiliensis yeast cells was evaluated by transmission
and scanning electron microscopy.
Results: In this study, the effects of farnesol on Paracoccidioides brasiliensis growth and dimorphism were
described. Concentrations of this isoprenoid ranging from 25 to 300 μM strongly inhibited P. brasiliensis
growth. We have estimated that the MIC of farnesol for P. brasiliensis is 25 μM, while the MLC is around
30 μM. When employing levels which don't compromise cell viability (5 to 15 μM), it was shown that
farnesol also affected the morphogenesis of this fungus. We observed about 60% of inhibition in hyphal
development following P. brasiliensis yeast cells treatment with 15 μM of farnesol for 48 h. At these farnesol
concentrations we also observed a significant hyphal shortening. Electron microscopy experiments
showed that, despite of a remaining intact cell wall, P. brasiliensis cells treated with farnesol concentrations
above 25 μM exhibited a fully cytoplasmic degeneration.
Conclusion: Our data indicate that farnesol acts as a potent antimicrobial agent against P. brasiliensis. The
fungicide activity of farnesol against this pathogen is probably associated to cytoplasmic degeneration. In
concentrations that do not affect fungal viability, farnesol retards the germ-tube formation of P. brasiliensis,
suggesting that the morphogenesis of this fungal is controlled by environmental conditions.
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Background
Essential oils are complex mixes of hydrophobic liquids
containing volatile aromatic compounds, which are prod-
ucts of plant secondary metabolism [1]. Of all the claimed
properties of essential oils, its antimicrobial activity is the
one which receives special attention due to the serious
threat that antibiotic resistance has become. Therefore,
the study of potential antibiotic compounds found in
these oils could be of interest in the development of novel
antimicrobial agents.
Farnesol is a sesquiterpene alcohol present in many essen-
tial oils – e.g. from Pluchea dioscoridis, Zea mays and Pitt-
osporum undulatum, possibly protecting these plants from
parasitic induced damages [2-4]. Recently, this sesquiter-
pene alcohol has been demonstrated to inhibit the growth
of some microorganisms, such as the human pathogens
Staphylococcus aureus [5,6] and Streptococcus mutans [7],
and the plant pathogenic fungus Fusarium graminearum
[8], signaling its potential use as an antimicrobial agent.
Farnesol also enhances microbial susceptibility to antibi-
otics, indicating a putative application as an adjuvant
therapeutic agent [9,10]. Although its mechanism of
action is not fully understood, it probably involves cell
membrane damages and impaired ergosterol synthesis
[10].
This sesquiterpenoid was also identified as a quorum-
sensing molecule produced by the dimorphic fungus Can-
dida albicans, where it prevents the fungal transition from
yeast to mycelium, and disrupts biofilm formation
[11,12].  C. albicans synthesizes farnesol from farnesyl
pyrophosphate (FPP), a well known intermediate of the
highly conserved sterol biosynthetic pathway [13]. A
recent study showed that farnesol increases the virulence
of C. albicans in a mouse infection model [14]. In another
work, it appears that farnesol is employed by C. albicans in
order to reduce competition with other microbes, since
this compound mediated apoptosis in the filamentous
fungus Aspergillus nidulans [15], and inhibited biofilm for-
mation in other Candida species [10,16].
In this study, we tested the effects of farnesol on Paracoc-
cidioides brasiliensis growth and morphogenesis. P. brasil-
iensis  is the etiologic agent of paracoccidioidomycosis
(PCM), a systemic human mycosis geographically con-
fined to Latin America [17,18]. This organism is a thermal
dimorphic fungus, which can be found as mycelium at
room temperature (25°C) and as yeast cells at body tem-
perature (37°C). Although little is known about the ecol-
ogy of this fungus, it is thought that infection occurs when
the mycelial form releases conidia or hyphal fragments to
the environment and, upon inhalation by the host, these
structures differentiate to the yeast form [19]. This dimor-
phic transition of mycelium to yeast phase seems to be
essential to the establishment of the infective process [20].
In this context, our results revealed that farnesol reduces
the viability of this pathogen and delays the dimorphism,
suggesting an antimicrobial activity against P. brasiliensis,
probably due the massive cytoplasmic organelles degener-
ation.
Methods
Fungal strain
Yeast cells of the virulent isolate 18 of P. brasiliensis (Pb18)
were maintained by weekly passages in semi-solid Fava
Neto's medium (0.3% protease peptone, 1% peptone,
0.5% beef extract, 0.5% yeast extract, 4% glucose, 0.5%
NaCl, 1.6% agar, pH 7.2) at 36°C, and were used after 6
– 9 days of growth. The fungal cells used in all experi-
ments were suspended in complex medium YPD (yeast-
peptone-dextrose), vigorously vortexed and counted in a
Neubauer chamber. The cell viability was determined by
vital Janus green stain [21]. C. albicans ATCC 10231, used
as a control, was also maintained on semi-solid Fava
Neto's medium at 36°C and transferred at regular inter-
vals. Under these conditions over 95% of C. albicans cells
remained in the yeast form.
P. brasiliensis growth assay upon farnesol treatment
In all assays, a mixture of stereoisomers of farnesol (assay
≥ 90%; GS, sum of isomers; Fluka, Sigma-Aldrich) was
diluted in 100% methanol. Working concentrations were
prepared in YPD medium.
For the in vitro growth assay, 2 × 105 P. brasiliensis yeast
cells per mL were inoculated in complex medium YPD
supplemented with farnesol at different final concentra-
tions (5, 10, 25, 50, 100, 150 and 300 μM), employing 96
well-plates in a final volume of 200 μL. Farnesol-free con-
trols were supplemented with 2% methanol, the farnesol
diluent. Cultures were allowed to grow at 36°C for 25
days. The number of cells at each specific time interval was
determined by measuring the OD absorption at 630 nm
of vigorously vortexed cultures. The growth curve of each
culture was prepared by plotting the logarithmic values of
OD630 vs. incubation time. All experiments were carried
out in triplicate. The Minimum Inhibitory Concentration
(MIC) for farnesol was defined as the lowest concentra-
tion that resulted in 90% of inhibition of cell growth
when compared to the farnesol-free control cells.
Effect of farnesol on P. brasiliensis cell viability
The analysis of cell viability was performed using the tetra-
zolium salt 3-[4,5-dimethylthiazol-2-yl]-2,5-diphe-
nyltetrazolium bromide (MTT; Sigma) in a colorimetric
assay that measures mitochondrial activity. To determine
the MLC (Minimal Lethal Concentration) of farnesol for
P. brasiliensis, 2 × 105 yeast cells/mL were incubated in
YPD medium with farnesol at the final concentrations ofAnnals of Clinical Microbiology and Antimicrobials 2009, 8:13 http://www.ann-clinmicrob.com/content/8/1/13
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2.5, 5, 7.5, 10, 12.5, 15, 17.5, 20, 22.5, 25, 27.5, 30, 50,
75, 100, 150 and 300 μM. After 15 days of incubation
with different concentrations of farnesol at 36°C (150
rpm) in 96-well tissue culture plates, a solution contain-
ing 5 mg of MTT per mL of 0.15 M phosphate-buffered
saline (PBS) was added to each well to reach a final con-
centration of 0.5 mg/mL. After incubation for 4 h at 36°C,
the medium containing MTT was partially removed, and
dimethyl sulfoxide (100 μL) was added to solubilize the
MTT formazan product. MTT formazan formation was
measured at 490 nm by using a spectrophotometer. Con-
trol wells contained medium plus MTT to determine back-
ground formazan values. All assays were done in
triplicate. The MLC for farnesol was defined as the lowest
concentration that resulted in 90% of cell death when
compared to the farnesol-free control cells.
The effect of farnesol on cell viability was also estimated
by colony counting. Yeast cells of P. brasiliensis were sus-
pended in YPD medium at a density of 2 × 105 cells/mL,
and farnesol was added to final concentrations of 5, 10,
25, 50 and 100 μM. Farnesol-free controls were supple-
mented with 2% methanol. After incubation at 36°C for
4 days in an orbital shaker (150 rpm), cells were harvested
by centrifugation (4000 × g/5 min), washed and plated on
brain heart infusion agar (BHI) supplemented with 4%
fetal calf serum (FCS), for at least 12 days to determine
their viability, expressed as colony forming units (CFU).
The survival rate of these cultures was compared to far-
nesol-free cultures. The number of single colonies on each
plate was counted and the percentage of cell killing calcu-
lated as (1 - N1/N2) × 100, where N1 is the mean of the
number of colonies from farnesol-treated P. brasiliensis
cells, and N2 is the mean of the number of colonies from
P. brasiliensis non-treated cells. The experiments were car-
ried out in triplicate.
Effect of farnesol on P. brasiliensis dimorphic transition
To evaluate the effects of farnesol on P. brasiliensis dimor-
phism, 2 × 105 yeast cells/mL were inoculated in YPD
medium and farnesol was added to final concentrations
of 5, 7.5, 10, 15, 20 and 25 μM. Cultures were incubated
for 48 h at 25°C in an orbital shaker (150 rpm). Farnesol-
free controls were supplemented with 2% methanol, the
farnesol diluent. Cell morphology was assessed by light
microscopy. The percentage of cells showing germ-tubes
after 24 h and 48 h of incubation was calculated. Addi-
tionally, the average size of the germ tubes was measured
after the same period of time. All experiments were carried
out in triplicate. The P. brasiliensis dimorphism from myc-
elium to yeast cells was also evaluated by the treatment of
the mycelial form with farnesol at different final concen-
trations (5, 10, and 25 μM), for 4 days at 36°C, following
exactly the same conditions described above for the tran-
sition in the opposite direction.
Transmission and Scanning electron microscopy
Transmission electron microscopy (TEM) was performed
according to the following standard procedure. Briefly, P.
brasiliensis yeast cells were cultivated at 36°C for 3 days in
YPD medium without (control supplemented with 2%
methanol) or with farnesol (25, 50 and 150 μM). Cells
were harvested by centrifugation at 4000 × g for 5 min,
washed four times with phosphate-buffered saline (PBS,
pH 7.2) and fixed overnight at 4°C (2% glutaraldehyde,
2% paraformaldehyde in 0.1 M sodium cacodylate buffer,
pH 7.2, with 3% sucrose and 3 mM CaCl2). After fixation,
cells were harvested by centrifugation (4000 × g/5 min),
and the pellet was washed four times in 0.1 M sodium
cacodylate buffer (4000 × g/15 min). Samples were post-
fixed for 1 hour (1% osmium tetroxide, 0.8% potassium
ferrocyanide in the same buffer), contrasted en bloc with
0.5% uranyl acetate, dehydrated through an ascending
acetone series and embedded in Spurr resin. The ultrathin
sections were contrasted with uranyl acetate/lead citrate
and observed in a TEM Jeol 1011 at 80 kV.
In order to prepare samples to scanning electron micros-
copy analysis, P. brasiliensis yeast cells treated with differ-
ent concentrations of farnesol (25 and 50 μM) for 5, 10
and 24 h, were fixed overnight at 4°C (2% glutaralde-
hyde, 2% paraformaldehyde in 0.1 M sodium cacodylate
buffer, pH 7.2, with 3% sucrose and 3 mM CaCl2), har-
vested by centrifugation (4000 × g/5 min), and the pellet
was washed four times in 0.1 M sodium cacodylate buffer
(4000 × g/15 min). Samples were post-fixed for 1 hour
(1% osmium tetroxide, 0.8% potassium ferrocyanide in
the same buffer), and then applied on a polylysine-coated
coverslip and serially dehydrated in acetone. The samples
were dried in a critical point drier (BAL-TEC CPD-030 –
Electron Microscopy Sciences, USA), coated with gold-
palladium (Balzers Union SCD-040 – Electron Micros-
copy Sciences, USA) and viewed using a JEOL (Tokyo,
Japan) JEM 840A electron microscope.
Statistical analysis
Statistical analyses were performed using the software
"Mynova", verson 1.3 (S. Brooks, Copyright 1993). The
statistical test applied was Student's t test. A P value ≤
0.001 was considered significant.
Results and discussion
Farnesol affects P. brasiliensis growth and viability
The incidence of fungal infections has dramatically
increased in the last two decades [22,23]. Simultaneously,
the resistance to antifungal agents has become an impor-
tant problem in several fungal diseases. In addition to the
drug resistance problem, the current antifungal therapies
are limited due the high toxicity of the agents and their
low efficacy rates [24].Annals of Clinical Microbiology and Antimicrobials 2009, 8:13 http://www.ann-clinmicrob.com/content/8/1/13
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PCM is commonly treated with sulfonamides, azoles and
amphotericin B [25]. In spite of the good efficacy of these
antifungal agents against P. brasiliensis, some of these
compounds, like amphotericin B, can also damage the
host cells [26]. Furthermore, Hanh et al. [27] described
the occurrence of ketoconazole resistant isolates of P. bra-
siliensis in PCM patients. The P. brasiliensis transcriptome
analysis revealed several ortholog genes related to trans-
membrane proteins that can function as efflux pumps
[28]. The existence of such genes augurs the possible
emergency of resistant isolates, emphasizing the impor-
tance of novel antimicrobial agent development.
In this context, the interest in studying the antimicrobial
activity of plant extracts and essential oils has increased in
recent years. San-Blas et al. [29] demonstrated that ajoene,
a compound from Allium sativum, inhibits the growth of
P. brasiliensis. These authors suggested that the integrity of
the fungal cytoplasmic membrane could probably be the
target of this garlic-derived compound, since ajoene pro-
motes changes in the phospholipid and fatty acid propor-
tions [30]. Furthermore, the association of ajoene and
chemotherapeutic drugs show a positive additive effect in
the treatment of mice infected with P. brasiliensis [31].
In this work we evaluated the role of farnesol, a sesquiter-
pene alcohol present in many essential oils [2-4,32], and
also produced as a quorum sensing molecule by C. albi-
cans, in P. brasiliensis growth and morphogenesis.
First, the effect of farnesol on P. brasiliensis growth was
evaluated. We verified that farnesol concentrations rang-
ing from 25 to 300 μM strongly inhibited P. brasiliensis
yeast cells growth, since the results obtained with three
different growth curves were equivalent (Figure 1A). Sim-
ilar patterns were observed with the mycelial form growth
curves (data not shown).
In order to evaluate if the effects of farnesol on P. brasilien-
sis growth were caused by an increase in mortality, a via-
bility assay based on metabolism (Figure 1B) was
performed (MTT assay). This test showed that the percent-
age of non-viable fungal cells increased proportionally
with farnesol concentrations, suggesting that farnesol has
a potent fungicide activity against P. brasiliensis. The same
behavior of farnesol on P. brasiliensis viability was
observed when we performed experiments based on CFU
counts (data not shown). The Figure 1A reveals that far-
nesol concentrations of 25 μM or higher have an inhibi-
tory effect on P. brasiliensis growth, while P. brasiliensis
metabolism completely ceased at the farnesol concentra-
tion of 30 μM (Figure 1B). According to these data we
have determined that the MIC of farnesol for P. brasiliensis
is 25 μM, while the MLC is 30 μM.
This role of farnesol in the inhibition of P. brasiliensis
growth and viability has also been verified in other micro-
organisms [6-8,33-36], suggesting that this compound
also possess an effective antimicrobial activity against P.
brasiliensis. Interestingly, our data indicate that P. brasilien-
sis  is more sensitive to farnesol than other pathogens
since, while for P. brasiliensis the MLC corresponds to 30
μM, the MLC is of 200 μM for the bacteria S. aureus and
Streptomyces tendae [6,33]. The bacterium S. mutans and
the fungus Candida dubliniensis show higher tolerances to
farnesol, with an MLC of 300 μM and 500 μM, respec-
tively [7,10].
Farnesol delays the dimorphic transition of P. brasiliensis
We have tested the effects of farnesol on P. brasiliensis
morphogenesis employing farnesol concentrations up to
25 μM, the MIC value determined for P. brasiliensis in this
study. Noteworthy, our results revealed that the addition
of exogenous farnesol at concentrations below 25 μM,
which do not affect P. brasiliensis growth, impaired the
transition from yeast to mycelium, as observed by micro-
scopic analyses of cellular morphology after 24 h and 48
h incubation (Figure 2A). When grown in the absence of
farnesol, all cells presented germ tubes after 24 h, while
when cultured in the presence of farnesol (up to 25 μM)
we observed an increasingly lower percentage of cells with
germ tubes after 24 h, with about 85% of cells without
germ tubes at 15 μM of farnesol (Figure 2B). In addition,
after 24 h, the germ tubes of cells treated with up to 15 μM
of farnesol were markedly smaller when compared to
those of control cells (Figure 2C). Figures 2B and 2C also
reveal that, up to15 μM, farnesol is acting on the morpho-
genesis instead of the viability of P. brasiliensis cells since
after 48 h of incubation we can observe an increase in
both, the number of cells with germ tubes – 60% of cell
with germ tubes at 15 μM of farnesol (Figure 2B), and in
the size of these structures (Figure 2C). These data strongly
suggest that in fact the farnesol at concentrations below
15 μM present an effect on the morphogenetic process of
P. brasiliensis without interfering with its viability, as
showed in figure 1B.
Similar concentrations of this isoprenoid also inhibited P.
brasiliensis mycelium to yeast transition, as verified after 4
days incubation of the mycelial form at 36°C (Figure 3).
The cultivation of P. brasiliensis in the presence of 5 and 10
μM of farnesol resulted in the impairment of the dimor-
phic transition, while, as expected, 25 μM of farnesol
completely abolished the fungal dimorphic transition,
probably by compromising cell viability.
Similar results were observed with C. albicans cells, where
farnesol also prevented germ tubes formation [11,37].
Other studies revealed that farnesol is also employed by
C. albicans to mediate antagonistic interactions with otherAnnals of Clinical Microbiology and Antimicrobials 2009, 8:13 http://www.ann-clinmicrob.com/content/8/1/13
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Effect of farnesol on the growth and viability of P. brasiliensis yeast cells Figure 1
Effect of farnesol on the growth and viability of P. brasiliensis yeast cells. (A) Growth curves of P. brasiliensis yeast cells 
incubated in the presence of different concentrations of farnesol. The number of cells at each specific time point was assessed 
by measuring the OD absorption at 630 nm, after vigorously shaking the cultures. The growth curve of each culture was pre-
pared by plotting the logarithmic values of OD630 vs. incubation time. (B) Viability of P. brasiliensis yeast cells cultivated with dif-
ferent concentrations of farnesol after 15 days of growth in the absence, or in the presence of farnesol (2.5 to 50 μM). The 
MTT assay was performed as described in methods section. MTT formazan formation was measured at 490 nm by using a 
spectrophotometer.Annals of Clinical Microbiology and Antimicrobials 2009, 8:13 http://www.ann-clinmicrob.com/content/8/1/13
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microorganisms [10,15,16]. Semighini et al. [15] showed
that exogenous farnesol triggers apoptosis in the filamen-
tous fungus A. nidulans. Moreover, the possibility that far-
nesol produced by C. albicans might affect A. nidulans was
evaluated in a co-culture model, showing that the co-cul-
tivation inhibits the growth of A. nidulans in a farnesol-
dependent manner [15]. A recent work reported that the
addition of farnesol to cultures of Pseudomonas aeruginosa
leads to a decrease in the amount of Pseudomonas qui-
nolone signal (PQS), and of the virulence factor pyocy-
anin produced by this pathogen. In addition, pyocyanin
and PQS levels in P. aeruginosa-C. albicans co-cultures were
reduced to 42.1% relative to a control pure culture of P.
aeruginosa. A similar decrease was verified in farnesol-
Effect of farnesol on P. brasiliensis morphogenesis Figure 2
Effect of farnesol on P. brasiliensis morphogenesis. P. brasiliensis yeast cells were grown for 24 h and 48 h at 25°C on dif-
ferent concentrations of farnesol. (A) Morphology of P. brasiliensis cells assessed by light microscopy after incubation with far-
nesol. (B) Percentage of cells showing germ tubes after 24 h and 48 h of cultivation in the absence, or in the presence of 
farnesol at different final concentrations. (C) Average size of the germ tubes formed in different concentrations of farnesol. 
Bars represent standard errors and different letters point to statistical relevance, P ≤ 0.001.Annals of Clinical Microbiology and Antimicrobials 2009, 8:13 http://www.ann-clinmicrob.com/content/8/1/13
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treated P. aeruginosa cultures, suggesting that farnesol may
be involved in inter-kingdom interactions [38].
Noteworthy was the inhibition of P. brasiliensis hyphal
development when yeast cells were grown on a condi-
tioned medium (CM), which corresponds to the filtered
supernatant of a high-density C. albicans culture added to
a conventional culture medium (data not shown). This
result suggests that P. brasiliensis germ tube formation
could be controlled by a soluble factor present in the C.
albicans culture supernatant [39]. In this sense, we pro-
pose that the farnesol-mediated communication between
C. albicans and other microorganisms is probably not spe-
cies-specific.
Curiously, tyrosol, another compound also identified as a
quorum-sensing molecule produced by C. albicans [40],
did not affect either P. brasiliensis growth or morphogene-
sis at concentrations up to 300 μM (data not shown).
Ultrastructural morphology analysis of P. brasiliensis 
yeast cells treated with farnesol
Although the role of farnesol as a potential antimicrobial
agent has been determined in this work, its mode of
action is not understood. Some studies have indicated a
possible interaction of farnesol with cell membranes of
certain microorganisms, including the bacteria S. mutans,
S. aureus and E. coli, [5-7,9,41], and the fungi C. albicans
and C. dubliniensis [10]. A hypothesis is that the hydro-
phobic property of farnesol favors its accumulation in the
membrane, causing membrane disruption [6].
In order to examine the effects of farnesol on the mor-
phology of P. brasiliensis at the ultrastructural level, yeast
cells were cultivated for three days on different concentra-
tions of farnesol (25, 50 and 150 μM) and examined by
transmission and scanning electron microscopy. As
observed in figure 4A and 4A', P. brasiliensis yeast cells cul-
tivated in the absence of farnesol (control cells supple-
mented with 2% of methanol) showed typical cellular
structures. Cytoplasmic organelles of P. brasiliensis cells,
such as mitochondria, nucleus, lysosomes, and endoplas-
matic reticulum could be clearly distinguished. Cell wall
and plasma membrane were also observed as intact struc-
Effects of farnesol on P. brasiliensis mycelium to yeast transi- tion Figure 3
Effects of farnesol on P. brasiliensis mycelium to yeast 
transition. P. brasiliensis (mycelium form) was incubated for 
4 days at 36°C on different concentrations of farnesol. (A) 
Control (no farnesol); (B) 5 μM farnesol; (C) 10 μM farnesol; 
(D) 25 μM farnesol.
Ultrastructural morphology of P. brasiliensis yeast cells  treated with different concentrations of farnesol Figure 4
Ultrastructural morphology of P. brasiliensis yeast 
cells treated with different concentrations of far-
nesol. Pannels A to D show the transmission electron 
micrographs of cells cultivated in the absence (A, A') and in 
the presence of farnesol (B to D). Cell structures like nucleus 
(N), mitochondria (M), endoplasmatic reticulum (Re), lisos-
some-like structures (l), plasma membrane and cell wall are 
preserved in control cells (arrows in A, A'). Cells cultivated 
in 25 μM (B), 50 μM (C) and 100 μM (D) of farnesol showed 
a degraded cytoplasm (DC) but an intact cell wall (arrows). 
In panel E, the scanning electron micrograph of 50 μM far-
nesol-treated yeast cells of P. brasiliensis is shown, revealing 
an intact fungal cell wall.Annals of Clinical Microbiology and Antimicrobials 2009, 8:13 http://www.ann-clinmicrob.com/content/8/1/13
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tures (Figure 4A and 4A'). These observations clearly dem-
onstrated that the use of 2% of methanol in all
experimental systems as farnesol's diluent, did not affect
P. brasiliensis cell morphology as well as growth and
dimorphic transition.
In contrast, yeast cells treated with increasing concentra-
tions of farnesol exhibited extensive cytoplasmic
organelles damages. Remarkable changes, resulting in
overall degeneration of internal structures, were found in
P. brasiliensis cells cultivated in the presence of 25, 50 and
100 μM of farnesol (Figure 4B–D). Various stages of deg-
radation were observed, ranging from cells with partially
digested cytoplasmic organelles, to cells with only the cell
wall remaining intact (Figure 4D). These results suggest
that death is probably associated to the disruption of cyto-
plasmic structures and internal cellular disintegration.
Scanning electron microscopy was also performed
employing P. brasiliensis yeast cells treated with farnesol,
as described in material and methods. Cells treated with
different concentrations of farnesol showed no major dif-
ferences at their surfaces when compared to the control
cells incubated without farnesol. Figure 4E shows the
scanning electron micrograph of the 50 μM farnesol-
treated yeast cells of P. brasiliensis, revealing an intact fun-
gal cell. This result corroborates the data obtained by
transmission electron microscopy, suggesting that far-
nesol does not affect the cell wall structure.
Similar results were reported by San-Blas et al. [29] study-
ing the antifungal activity of ajoene, which blocks the
growth of P. brasiliensis by inhibiting phosphatidylcholine
synthesis [30]. Curiously, farnesol induces apoptosis in
tumorigenic cells by a similar mode of action [42,43], sug-
gesting an antiproliferative mechanism shared by ajoene
and farnesol.
Moreover, our findings show that the fungicidal mecha-
nism of farnesol is probably associated to the disruption
of all cytoplasmic cellular organelles. A similar cytoplasm
disintegration also occurs after the ingestion of P. brasil-
iensis  yeast cells by cytokine-activated murine macro-
phages [44], indicating that this is possibly a common
event in response to a stress condition.
In order to understand the mode of action of farnesol on
P. brasiliensis, a microarray large scale analysis of gene
expression, as well as assays to evaluate the cell death
pathway activated in response to farnesol, should be per-
formed. Of major interest is the analysis of the expression
of genes related to phospholid and sterol synthesis path-
ways, as well and those related to the apoptotic process,
which are in progress.
Conclusion
In summary, our data indicate that farnesol acts as a
potent antimicrobial agent against P. brasiliensis, which is
very sensitive to this sesquiterpene alcohol. The fungicide
activity of farnesol in this pathogen is probably associated
to cytoplasmic degeneration, in spite of the apparent cell
wall integrity, as observed by transmission and scanning
electron micrographs. Although the antimicrobial activity
of farnesol has been clearly shown, additional studies
involving animal models need to be performed to assess
the potential effects of farnesol in vivo. It must be empha-
sized that the toxicity of exogenously administrated far-
nesol on mice is negligible, as shown by Navarathna et al.
[14]. Besides the observation of no significant gross
changes in control and treated mice examined at
necropsy, these authors verified that the oral (20 mM in
water) or intraperitoneal (1 ml of 20 mM) administration
of farnesol was harmless to mice, since there were no dif-
ferences in weight or water ingestion between control and
farnesol-treated animals.
In this sense, the antagonistic property of farnesol against
P. brasiliensis cells is particularly interesting, since it could
be further explored in order to evaluate its possible use as
an antimicrobial agent.
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